| Literature DB >> 33546218 |
Jordi Maggi1, Samuel Koller1, Luzy Bähr1, Silke Feil1, Fatma Kivrak Pfiffner1, James V M Hanson2, Alessandro Maspoli1, Christina Gerth-Kahlert2, Wolfgang Berger1,3,4.
Abstract
The purpose of this study was to develop a flexible, cost-efficient, next-generation sequencing (NGS) protocol for genetic testing. Long-range polymerase chain reaction (PCR) amplicons of up to 20 kb in size were designed to amplify entire genomic regions for a panel (n = 35) of inherited retinal disease (IRD)-associated loci. Amplicons were pooled and sequenced by NGS. The analysis was applied to 227 probands diagnosed with IRD: (A) 108 previously molecularly diagnosed, (B) 94 without previous genetic testing, and (C) 25 undiagnosed after whole-exome sequencing (WES). The method was validated with 100% sensitivity on cohort A. Long-range PCR-based sequencing revealed likely causative variant(s) in 51% and 24% of proband from cohorts B and C, respectively. Breakpoints of 3 copy number variants (CNVs) could be characterized. Long-range PCR libraries spike-in extended coverage of WES. Read phasing confirmed compound heterozygosity in 5 probands. The proposed sequencing protocol provided deep coverage of the entire gene, including intronic and promoter regions. Our method can be used (i) as a first-tier assay to reduce genetic testing costs, (ii) to elucidate missing heritability cases, (iii) to characterize breakpoints of CNVs at nucleotide resolution, (iv) to extend WES data to non-coding regions by spiking-in long-range PCR libraries, and (v) to help with phasing of candidate variants.Entities:
Keywords: ABCA4; BEST1; CNV; NGS; PRPH2; diagnostics; genetic testing; long-range PCR; missing heritability; phasing; retinal diseases; sequencing
Mesh:
Substances:
Year: 2021 PMID: 33546218 PMCID: PMC7913364 DOI: 10.3390/ijms22041508
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923